Chugai Pharmaceutical Co., Ltd.
CHGCF
$47.72
$1.312.82%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.78% | -- | -- | -72.77% | -- |
| Total Depreciation and Amortization | 2.11% | -- | -- | -7.10% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.89% | -4,048.33% | -69.39% | -381.04% | 61.77% |
| Change in Net Operating Assets | -25.80% | 291.18% | -72.03% | 176.88% | -43.37% |
| Cash from Operations | -16.17% | 82.40% | -35.64% | 18.75% | -29.60% |
| Capital Expenditure | -8,960.58% | -41.25% | -73.93% | 101.05% | 59.43% |
| Sale of Property, Plant, and Equipment | 143.46% | 6,771.62% | -- | -102.84% | -104.99% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -762.53% | 75.62% | -219.16% | -363.87% | -78.38% |
| Cash from Investing | -846.79% | 64.26% | -162.47% | -389.86% | 18.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.58% | -- | -- | -- | -- |
| Issuance of Common Stock | -25.00% | -42.11% | 53.33% | -68.00% | -38.02% |
| Repurchase of Common Stock | -200.00% | 50.00% | 66.67% | 50.00% | -200.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 12.47% | -40.06% | 23.73% | 11.44% |
| Other Financing Activities | -6.03% | -96.24% | 97.43% | -296.21% | 2.51% |
| Cash from Financing | -9.82% | -2.43% | -38.93% | 14.53% | 11.43% |
| Foreign Exchange rate Adjustments | 79.11% | 2.27% | -148.72% | 1,325.21% | 404.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 2.94% | 188.16% |
| Net Change in Cash | -121.67% | 215.05% | -2,815.51% | 3.56% | -85.37% |